Literature DB >> 11986005

Effects on endogenous acetaldehyde production by disulfiram and ethanol feeding on rat pancreas.

Z J He1, P Ericksson, H Alho, A Harmoinen, I Nordback.   

Abstract

Exogenous acetaldehyde infusion can induce pancreatitis-like injury of the pancreas in some isolated pancreas models, whereas in vivo such treatment has failed to induce pancreatitis. In vivo exogenous acetaldehyde may not be effective because it is rapidly metabolized. The aim of this study was to investigate whether endogenous acetaldehyde accumulates in the pancreas after ethanol feeding when acetaldehyde metabolism is blocked by disulfiram, and whether this treatment can induce pancreatitis-like injury in the rat. The liver was studied for comparison. In part I of the experiment, adult male Wistar rats were given water (n = 24), ethanol (n = 24), disulfiram (n = 24), and ethanol plus disulfiram for 1 week (n = 24) or 3 weeks (n = 24) and for 3 weeks with (n = 6) and without (n = 6) hypovolemia. In part II of the experiment, rats were given water (n = 6), ethanol (n = 6), and high-dose disulfiram (n = 6) and ethanol plus high-dose disulfiram (n = 6). Ethanol and acetaldehyde concentrations in blood, liver, and pancreas were measured. Animal behavior was monitored, and weight changes, plasma amylase activity, water content, and histomorphology of the pancreas and liver were studied without knowing the group. No increases in plasma amylase activity and no histomorphologic changes in the pancreas were observed under light or electron microscopy in part I of the experiment. In part II, treatment with ethanol induced acetaldehyde accumulation in the liver (33.6 +/- 2.6 micromol/L), but to a lesser degree in the blood (9.6 +/- micromol/L) and pancreas (5.0 +/-.2 micromol/L). Ethanol plus disulfiram induced marked accumulation of acetaldehyde in the liver (83.2 +/- 15.9 micromol/L), blood (280.0 +/- 47.4 micromol/L), and pancreas (43.6 +/- 4.7 micromol/L). When tissue acetaldehyde levels reached 30 to 40 micromol/L, we found a decrease in zymogen granules along with formation of small intracytoplasmic vacuolizations in the acinar cells and accumulation of lipid droplets in the hepatocytes, whereas physiologic signs of pancreatitis (hyperamylasemia, edema) or increases in liver enzymes did not develop. High levels of acetaldehyde accumulate in the liver and pancreas with the treatment described. Although this was accompanied by lipid degeneration of the hepatocytes and some subcellular changes in the acinar cells, physiologic signs of pancreatitis did not develop. Thus acetaldehyde accumulation alone, or in combination with hypovolemia, is not responsible for the induction of acute pancreatitis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11986005     DOI: 10.1016/s1091-255x(01)80092-5

Source DB:  PubMed          Journal:  J Gastrointest Surg        ISSN: 1091-255X            Impact factor:   3.452


  35 in total

1.  Effect of a high dose of ethanol on serum pancreatic enzymes in young healthy adults.

Authors:  M Jaakkola; P Sillanaukee; H Suomalainen; T Koivula; I Nordback
Journal:  Am J Gastroenterol       Date:  1992-04       Impact factor: 10.864

2.  The determination of acetaldehyde in biological samples by head-space gas chromatography.

Authors:  C J Eriksson; H W Sippel; O A Forsander
Journal:  Anal Biochem       Date:  1977-05-15       Impact factor: 3.365

3.  Recommended methods for the determination of four enzymes in blood.

Authors: 
Journal:  Scand J Clin Lab Invest       Date:  1974-06       Impact factor: 1.713

Review 4.  Xanthine oxidase: biochemistry, distribution and physiology.

Authors:  D A Parks; D N Granger
Journal:  Acta Physiol Scand Suppl       Date:  1986

Review 5.  Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury.

Authors:  D N Granger
Journal:  Am J Physiol       Date:  1988-12

6.  Cytokines, growth factors, and oxidative stress in HepG2 cells treated with ethanol, acetaldehyde, and LPS.

Authors:  M C Gutiérrez-Ruiz; S C Quiroz; V Souza; L Bucio; E Hernández; I P Olivares; L Llorente; F Vargas-Vorácková; D Kershenobich
Journal:  Toxicology       Date:  1999-06-15       Impact factor: 4.221

7.  Detailed characterization of experimental acute alcoholic pancreatitis.

Authors:  I H Nordback; J L Olson; V P Chacko; J L Cameron
Journal:  Surgery       Date:  1995-01       Impact factor: 3.982

8.  Effects of acute ethanol administration on the hepatic xanthine dehydrogenase/oxidase system in the rat.

Authors:  L G Sultatos
Journal:  J Pharmacol Exp Ther       Date:  1988-09       Impact factor: 4.030

9.  The mechanism of conversion of xanthine dehydrogenase to xanthine oxidase in acute pancreatitis in the canine isolated pancreas preparation.

Authors:  I H Nordback; J L Cameron
Journal:  Surgery       Date:  1993-01       Impact factor: 3.982

10.  Role of acetaldehyde in the ethanol-induced impairment of hepatic glycoprotein secretion in the rat in vivo.

Authors:  G D Volentine; K A Ogden; D K Kortje; D J Tuma; M F Sorrell
Journal:  Hepatology       Date:  1987 May-Jun       Impact factor: 17.425

View more
  3 in total

1.  Role of Acetaldehyde in Ethanol Reversal of Tolerance to Morphine-Induced Respiratory Depression in Mice.

Authors:  Rob Hill; Alexandra Conibear; William Dewey; Eamonn Kelly; Graeme Henderson
Journal:  Adv Drug Alcohol Res       Date:  2022-01-31

2.  Drug interaction between ethanol and 3,4-methylenedioxymethamphetamine ("ecstasy").

Authors:  Vijay V Upreti; Natalie D Eddington; Kwan-Hoon Moon; Byoung-Joon Song; Insong J Lee
Journal:  Toxicol Lett       Date:  2009-04-05       Impact factor: 4.372

3.  Differential cytotoxicity, ER/oxidative stress, dysregulated AMPKα signaling, and mitochondrial stress by ethanol and its metabolites in human pancreatic acinar cells.

Authors:  Mukund P Srinivasan; Kamlesh K Bhopale; Anna A Caracheo; Lata Kaphalia; Gopalakrishnan Loganathan; Appakalai N Balamurugan; Cristiana Rastellini; Bhupendra S Kaphalia
Journal:  Alcohol Clin Exp Res       Date:  2021-04-02       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.